Bajaj Healthcare Launches Antiviral Tablets Favijaj for the Treatment of COVID-19
In face of the rising COVID cases in the country, Indian pharmaceutical company Bajaj Healthcare has announced the launch of its anti-viral drug Favipiravir, under the brand name Favijaj for the treatment of ‘mild to moderate COVID-19 patients’. This comes as the country is in the midst of a second wave of the coronavirus pandemic that…